Income Taxes
The following table presents components of loss before income taxes for the periods presented (in thousands): | | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
| | 2025 | | 2024 | | 2023 |
| United States | | $ | 34,312 | | | $ | (22,903) | | | $ | (80,348) | |
| International | | 10,630 | | | 10,148 | | | 925 | |
| Income (loss) before income taxes | | $ | 44,942 | | | $ | (12,755) | | | $ | (79,423) | |
Provision for (benefit from) income taxes for the periods presented consisted of (in thousands): | | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Current: | | | | | | |
| U.S. federal | | $ | 16 | | | $ | 519 | | | $ | — | |
| U.S. state | | 1,866 | | | 2,728 | | | 2,531 | |
| Foreign | | 2,674 | | | 1,628 | | | (243) | |
| Total provision for income taxes - Current | | 4,556 | | | 4,875 | | | 2,288 | |
| | | | | | |
| Deferred: | | | | | | |
| U.S. federal | | 191 | | | (4,308) | | | — | |
| U.S. state | | 92 | | | (1,174) | | | — | |
| Foreign | | 687 | | | 647 | | | 53 | |
| Total provision for (benefit from) income taxes - Deferred | | 970 | | | (4,835) | | | 53 | |
| Total provision for income taxes | | $ | 5,526 | | | $ | 40 | | | $ | 2,341 | |
The Company recorded current income tax expense during 2025 principally due to U.S. state tax attribute utilization limitations and foreign income produced by the Company’s intercompany operating model. As a result of adopting ASU 2023-09 retroactively, the Company has revised certain disclosures to align with enacted requirements and has conformed prior year disclosures for comparability. Income tax expense (benefit) differed from the amount computed by applying the U.S. federal statutory income tax rate of 21% to pre-tax income (loss) for the periods presented as a result of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | |
| | 2025 | | 2024 | | 2023 |
| U.S. federal tax at statutory rate | | $ | 9,438 | | | 21 | % | | $ | (2,679) | | | 21 | % | | $ | (16,676) | | | 21 | % |
| | | | | | | | | | | | |
| Domestic federal reconciling items: | | | | | | | | | | | | |
| Tax credits | | | | | | | | | | | | |
| Research and Development tax credit | | (224) | | | — | % | | (2,766) | | | 22 | % | | (1,681) | | | 2 | % |
| | | | | | | | | | | | |
| Nontaxable and Nondeductible Items: | | | | | | | | | | | | |
| Stock-based compensation | | 21,476 | | | 48 | % | | 17,905 | | | (140) | % | | 11,359 | | | (14) | % |
| Officers’ compensation | | 2,196 | | | 5 | % | | 4,473 | | | (35) | % | | 6,417 | | | (8) | % |
| Transaction costs | | 19 | | | — | % | | 862 | | | (7) | % | | 415 | | | (1) | % |
| State taxes deduction | | (509) | | | (1) | % | | (277) | | | 2 | % | | (94) | | | — | % |
| Other | | (170) | | | — | % | | 303 | | | (2) | % | | 322 | | | — | % |
| | | | | | | | | | | | |
| Cross-Border Tax Laws: | | | | | | | | | | | | |
| Base Erosion Anti-Abuse Tax | | — | | | — | % | | (7,752) | | | 61 | % | | 7,752 | | | (10) | % |
| Net Controlled Foreign Corporations Tested Income Exclusion | | 507 | | | 1 | % | | — | | | — | % | | (3,831) | | | 5 | % |
| US Branch tax impact | | 898 | | | 2 | % | | 381 | | | (3) | % | | 132 | | | — | % |
| | | | | | | | | | | | |
| Other Adjustments: | | | | | | | | | | | | |
| Tax expense (benefit) from acquisition / reorganizations | | 207 | | | — | % | | (4,308) | | | 34 | % | | — | | | — | % |
| Net Operating Loss Carryforward adjustment | | — | | | — | % | | (1,241) | | | 10 | % | | — | | | — | % |
| Fixed Assets deferred adjustments | | 158 | | | — | % | | (788) | | | 6 | % | | (72) | | | — | % |
| Miscellaneous deferred adjustments | | 225 | | | 1 | % | | (1,013) | | | 8 | % | | (525) | | | 1 | % |
| Return-to-Provision adjustments | | (317) | | | (1) | % | | 35 | | | — | % | | (170) | | | — | % |
| | | | | | | | | | | | |
| Change in valuation allowance | | (31,565) | | | (70) | % | | (6,176) | | | 48 | % | | (4,077) | | | 5 | % |
| | | | | | | | | | | | |
Domestic state and local income taxes, net of federal effect (1) | | 1,601 | | | 4 | % | | 252 | | | (2) | % | | 1,386 | | | (2) | % |
| | | | | | | | | | | | |
| Foreign Reconciling Items: | | | | | | | | | | | | |
| Australia | | | | | | | | | | | | |
| Return-to-Provision Adjustments | | 548 | | | 1 | % | | (161) | | | 1 | % | | 44 | | | — | % |
| Other | | 57 | | | — | % | | 185 | | | (1) | % | | (76) | | | — | % |
| United Kingdom | | | | | | | | | | | | |
| Stock-based compensation, net | | 716 | | | 2 | % | | 593 | | | (5) | % | | (963) | | | 1 | % |
| Other | | (274) | | | (1) | % | | 828 | | | (6) | % | | 639 | | | (1) | % |
| India | | | | | | | | | | | | |
| Write-off of Income Tax Receivables | | 831 | | | 2 | % | | — | | | — | % | | — | | | — | % |
| Other | | (385) | | | (1) | % | | (580) | | | 5 | % | | — | | | — | % |
| Other Foreign Jurisdictions | | (1,228) | | | (3) | % | | (530) | | | 4 | % | | 306 | | | — | % |
| Foreign Withholding Taxes | | 866 | | | 2 | % | | — | | | — | % | | — | | | — | % |
| | | | | | | | | | | | |
| Changes in Unrecognized Tax Benefits: | | 455 | | | 1 | % | | 2,494 | | | (20) | % | | 1,734 | | | (2) | % |
| | | | | | | | | | | | |
| Tax provision for income taxes | | 5,526 | | | 12 | % | | 40 | | | — | % | | 2,341 | | | (3) | % |
| | | | | | | | | | | | |
(1) State taxes in Illinois, Texas, New Hampshire and Oregon made up the majority (greater than 50%) of the current tax effect in this category.
Cash paid for income taxes, net of refunds received, by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 is as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
| | 2025 | | 2024 | | 2023 |
| US Federal * | | $ | 740 | | | $ | 745 | | | $ | — | |
| | | | | | |
| US State and Local: | | | | | | |
| Illinois | | 560 | | | 978 | | | 380 | |
| Pennsylvania * | | — | | | 368 | | | 200 | |
| Texas | | 247 | | | 295 | | | 205 | |
| New York * | | — | | | — | | | 114 | |
| Other states | | 1,282 | | | 765 | | | 251 | |
| Total State and Local | | 2,089 | | | 2,406 | | | 1,150 | |
| | | | | | |
| Foreign: | | | | | | |
| United Kingdom * | | 1,460 | | | — | | | — | |
| Canada * | | — | | | 317 | | | 178 | |
| Philippines * | | — | | | — | | | 118 | |
| Other foreign | | 554 | | | 283 | | | 143 | |
| Total Foreign | | 2,014 | | | 600 | | | 439 | |
| | | | | | |
| Total Worldwide | | $ | 4,843 | | | $ | 3,751 | | | $ | 1,589 | |
| | | | | | |
* Jurisdiction did not incur tax payments which exceeded the disclosure threshold for years with no payments shown.
The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities as of December 31, 2025 and 2024 related to the following (in thousands): | | | | | | | | | | | | | | |
| | December 31, |
| | 2025 | | 2024 |
| Deferred tax assets: | | | | |
| Net operating loss and credit carryforwards | | $ | 97,816 | | | $ | 91,826 | |
| Capitalized R&D costs | | 40,223 | | | 78,961 | |
| Accrued liabilities | | 1,781 | | | 872 | |
| Provision for credit losses | | 1,381 | | | 671 | |
| Property and equipment | | 103 | | | 35 | |
| Amortizable intangibles | | — | | | — | |
| Deferred revenue | | 3,148 | | | 3,687 | |
| Accrued compensation | | 6,396 | | | 5,797 | |
| Long-term lease liabilities | | 18,169 | | | 15,928 | |
| Stock-based compensation | | 6,697 | | | 10,224 | |
| Deferred interest expense | | — | | | 349 | |
| Other | | 1,259 | | | 755 | |
| | | | |
| Gross deferred tax assets | | 176,973 | | | 209,105 | |
| Valuation allowance | | (75,701) | | | (123,141) | |
| Net deferred tax assets | | 101,272 | | | 85,964 | |
| Deferred tax liabilities: | | | | |
| Property and equipment | | (11,637) | | | (8,647) | |
| Amortizable intangibles | | (5,399) | | | (7,697) | |
| Right of use assets | | (15,663) | | | (13,493) | |
| Deferred contract acquisition costs | | (65,576) | | | (52,663) | |
| Other | | (214) | | | — | |
| Gross deferred tax liabilities | | (98,489) | | | (82,500) | |
| Net deferred taxes | | $ | 2,783 | | | $ | 3,464 | |
| | | | |
With the exception of Russia, the Company has not provided for U.S. income taxes on undistributed earnings of its foreign subsidiaries because it intends to permanently re-invest those earnings outside the United States. The Company has plans to liquidate its Russian subsidiary. As such, the Company no longer asserts an intention to permanently re-invest those earnings.
A valuation allowance is provided for deferred tax assets where the recoverability of the assets is uncertain. The determination to provide a valuation allowance is dependent upon the assessment of whether it is more likely than not that sufficient future taxable income will be generated to utilize the deferred tax assets. Based on the weight of the available evidence, which includes the Company’s historical operating losses, lack of taxable income and the accumulated deficit for the year ended December 31, 2025, the Company has provided a valuation allowance against its U.S. net deferred tax assets. The Company has recorded net foreign deferred tax assets associated with its Australia, Germany, India and the U.K. operations totaling $2.8 million since management has assessed it is more likely than not that the results of future operations within these jurisdictions will generate sufficient taxable income to realize the deferred tax assets. The foreign deferred tax assets cannot increase its U.S. valuation allowance. The net change in the valuation allowance for the years ended December 31, 2025 and 2024 were decreases of $47.4 million and $11.7 million, respectively. The decrease of the valuation allowance in the current year was primarily attributed to the acceleration of domestic research and development expenditures under H.R. 1 (“OBBBA”), historically capitalized under Section 174.
As of December 31, 2025, the Company had net operating loss carryforwards for federal, state and foreign income tax purposes of $344.1 million, $247.1 million and $5.5 million, respectively, available to reduce future income subject to income taxes. If not utilized, various amounts of state net operating loss carryforwards will begin to expire in 2026. The federal and foreign net operating losses will not expire. As of December 31, 2025, the
Company also had gross research credit carryforwards for federal and California state tax purposes of $14.3 million and $8.2 million, available to reduce future income subject to income taxes. The federal research credit carryforwards will expire between 2026 and 2045. The California state research credits do not expire. The IRC imposes restrictions on the utilization of net operating losses and credits in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use net operating losses and credits may be subject to substantial limitation as prescribed under the IRC Sections 382 and 383 and similar state provisions. Events that may cause limitations in the amount of the net operating losses and credits that the Company may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. In the event the Company has changes in ownership, net operating losses and research and development credit carryforwards, which are fully reserved by the deferred tax asset valuation allowance, could be limited and may expire unutilized.
Unrecognized Tax Benefits
The table below shows the changes in the gross amount of unrecognized tax benefits for the periods presented (in thousands): | | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Unrecognized benefit — beginning of period | | $ | 13,575 | | | $ | 11,124 | | | $ | 9,415 | |
| Gross increases — current year tax positions | | 490 | | | 2,502 | | | 1,413 | |
| Gross increases — prior year tax positions | | — | | | 40 | | | 299 | |
| Gross decreases — prior year tax positions | | (83) | | | (91) | | | (3) | |
| Settlements with tax authorities | | — | | | — | | | — | |
| Unrecognized benefit — end of period | | $ | 13,982 | | | $ | 13,575 | | | $ | 11,124 | |
As of each of December 31, 2025 and 2024, the Company had unrecognized tax benefits that, if recognized, would impact its effective tax rate by $1.0 million. The Company recognizes interest and penalties related to uncertain tax positions as income tax expense, which has cumulatively been immaterial to the financial statements.
The Company is subject to taxation in the United States, various states and several foreign jurisdictions. Due to the Company’s net carryover of unused tax attributes, all years from 2003 forward remain subject to future examination by the U.S. federal and state tax authorities. The Company’s foreign tax returns are open to audit under the statutes of limitation of the respective foreign countries in which the subsidiaries are located.